Fexofenadine
Allegra · ATC code R06AX26
Also known as: Fexofenadin, Feksofenadin, Fexofenadina, Fexofénadine · Brand names: Fexofenaderm, Fexofenadin Puren, Fexofenadin Winthrop, Fexofenadinhydrochlorid Cipla, Telfast, Allegra, Alertec, Fatoyya, Feksine, Fexadyne, Fexofen, Fexonad, Mayfex, Vivafeks
- Key facts
- Active substance
- Fexofenadine
- Drug class
- Histamine antagonist
- ATC code
- R06AX26
- Authorisation
- authorised nationally; no central EU authorisation
- Information as of
- 2026-11-05
Key facts
Fexofenadine is an antihistamine. Per the US OTC label it temporarily relieves the symptoms of hay fever and other upper respiratory allergies.
What it is used for
- Temporary relief of hay fever and other upper respiratory allergy symptoms: runny nose, sneezing, itchy and watery eyes, itching of the nose or throat
Dosing
- Adults and children 12 years and over: one 180 mg tablet with water once a day; not more than 1 tablet in 24 hours
Contraindications
- Previous allergic reaction to the product or any of its ingredients
Important warnings
- Kidney disease: a different dose may be needed – ask a doctor first
- Stop use and seek medical help right away if an allergic reaction occurs
Side effects
- The US OTC label lists no side effects
Pregnancy and breastfeeding
- Pregnancy or breast-feeding: ask a health professional before use
Summary of the official product information, written with AI on 2026-11-06. Every number was checked automatically against the original text. Not reviewed by a physician – the full official text is authoritative.
Common questions – ask Medelix
For patients
Patient information (US)
This product has no separate US patient information.
Authorisation and brand names by country
Medicines with exactly this active-substance composition, as listed in the national registers – alphabetical and without ranking. Whether a product is currently available is not shown here.
Germany
- FexofenadermDermapharm Ag · 1 register entry
- Fexofenadin PurenPuren Pharma Gmbh & Co. Kg · 1 register entry
- Fexofenadin WinthropWinthrop Arzneimittel Gmbh · 1 register entry
- Fexofenadinhydrochlorid CiplaCipla Europe Nv · 1 register entry
- TelfastA. Nattermann & Cie. Gmbh · 1 register entry
Source: EMA – Article 57 product data (EU/EEA), as of 2026-11-05
Austria
- AllegraOpella Healthcare Austria Gmbh · 1 register entry
Source: EMA – Article 57 product data (EU/EEA), as of 2026-11-05
Turkey
- AlertecWORLD MEDICINE İLAÇ SAN. VE TİC. A.Ş. · 2 register entries
- AllegraOPELLA HEALTHCARE TÜKETİCİ SAĞLIĞI A.Ş. · 2 register entries
- FatoyyaDR. SERTUS İLAÇ SAN. VE TİC. LTD. ŞTİ. · 2 register entries
- FeksineDROGSAN İLAÇLARI SAN. VE TİC. A.Ş. · 4 register entries
- FexadyneALİ RAİF İLAÇ SAN. A.Ş. · 4 register entries
- FexofenSANOVEL İLAÇ SAN. VE TİC. A.Ş. · 8 register entries
- FexonadNOBEL İLAÇ SAN. VE TİC. A.Ş. · 4 register entries
- MayfexRECORDATİ İLAÇ SAN. VE TİC. A.Ş. · 4 register entries
- VivafeksACTAVİS İLAÇLARI A.Ş. · 2 register entries
Source: TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, as of 2026-11-05
Brand names in 24 more European countries
- Belgium
- Allegra Tab, Otrifex, Telfast
- Bulgaria
- Алегра, Евофекс
- Croatia
- Allegra, Feksofenadinklorid Cipla, Telfast
- Cyprus
- Allegra Hives
- Czechia
- Ewofex, Fexigra
- Denmark
- Alnodine, Alterfast, Altifex, Clarifast, Fexofenadin Cipla, Fexofenadine Hydrochloride Viatris, Histafast, Nefoxef, Telfast
- Finland
- Fexofenadine Ratiopharm, Telfast
- France
- Allervi, Fexofenadine Arrow, Fexofenadine Biogaran, Fexofenadine Viatris, Fexofenadine Zentiva, Telfast
- Greece
- Allegra
- Hungary
- Allegra, Fexgen, Telfast
- Iceland
- Fexofenadine Hydrochloride Viatris, Nefoxef, Telfast
- Ireland
- Fexo Allergy Relief, Fexofast, Fexofenadine Hydrochloride Azure Pharmaceuticals, Fexofenadine Hydrochloride Chanelle Medical, Flixrelief, Telfast
- Italy
- Fexallegra, Fexofenadina, Fexyna, Fixodin, Telfast
- Lithuania
- Altiva
- Luxembourg
- Allegra Tab, Telfast
- Malta
- Telfast
- Netherlands
- Allegra Fexotabs, Fexofenadine Hcl Amarox, Fexofenadine Hcl Mylan, Fexofenadine Hcl Teva, Fexofenadine Hcl Viatris, Fexofenadine Hydrochloride Aurobindo, Fexofenadine Hydrochloride Marel, Fexofenadine Hydrochloride Sameko, Fexofénadine Teva, Otrifex, Telfast
- Norway
- Altifex, Feksofenadin Cipla, Telfast
- Poland
- Allegra, Allertec Fexo, Fexahist, Fexofast, Fexofenadine Hydrochloride Cipla, Fexomed, Telfast, Telfexo
- Portugal
- Allergodil Od, Fexofenadina Generis Phar, Fexofenadina Nazonite, Nalerge, Telfast
- Slovakia
- Fixit
- Slovenia
- Alerfen, Allegra, Telfast
- Spain
- Fexofenadina Cipla, Fexofenadina Opella, Riniwel, Telfast
- Sweden
- Allegra, Altifex, Fexofenadin Abece, Fexofenadin Apofri, Fexofenadin Cipla, Fexofenadine Amarox, Fexofenadine Hydrochloride Viatris, Nefoxef, Telfast
EMA – Article 57 product data (EU/EEA), 2026-11-05
Medelix receives no money from pharmaceutical companies. Brand names are listed alphabetically and without ranking.
Other substances in the same group
Another question about this substance?
Medelix answers clinical questions from guidelines, studies and product information – every claim with its source.
Sources
- U.S. Food and Drug Administration. Fexofenadine HCL (CVS) – Prescribing Information, 2025-12-19. DailyMed (NLM), 2026-11-05. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=013ef192-5184-b720-e063-6394a90a98c4
- EMA – Article 57 product data (EU/EEA), 2026-11-05. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- EMA – Article 57 product data (EU/EEA), 2026-11-05. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, 2026-11-05. https://www.titck.gov.tr/dinamikmodul/85
- Wikidata (CC0): ATC R06AX.
Editorial: Medelix editorial team · last updated 2026-11-05 · How these pages are made · Report an error
Source: U.S. Food and Drug Administration (FDA), over-the-counter Drug Facts label, via DailyMed (NLM); public domain. Not advertising, not a treatment recommendation. For questions about your own treatment, ask your doctor or pharmacist.